Biointron is excited to announce our newest webinar offering:
“Accelerating Antibody Drug Discovery with Fully Human Antibody Mouse HUGO-Ab™ and High-Throughput Single B Cell Screening AbDrop™”
Featuring Shun Zhou, Ph.D, the R&D Director at Cyagen Biosciences, this webinar promises to be an in-depth learning experience for anyone interested in antibody drug discovery, humanization, and the single B cell screening process.
This topic explores the revolutionary potential of the genome-edited mouse HUGO-Ab, where endogenous VH and VL genes are replaced by fully human VH and VL genes in situ, enabling the generation of fully human antibody molecules. When combined with microfluidic technology-enhanced single B cell screening, this approach allows for the high-throughput and efficient discovery of antibody drug molecules.
